171 related articles for article (PubMed ID: 29182792)
1. Ex vivo Culture of Duodenal Biopsies from Patients with Dermatitis Herpetiformis Indicates that Transglutaminase 3 Antibody Production Occurs in the Gut.
Hietikko M; Hervonen K; Ilus T; Salmi T; Huhtala H; Laurila K; Rauhavirta T; Reunala T; Kaukinen K; Lindfors K
Acta Derm Venereol; 2018 Mar; 98(3):366-372. PubMed ID: 29182792
[TBL] [Abstract][Full Text] [Related]
2. Intestinal TG3- and TG2-Specific Plasma Cell Responses in Dermatitis Herpetiformis Patients Undergoing a Gluten Challenge.
Sankari H; Hietikko M; Kurppa K; Kaukinen K; Mansikka E; Huhtala H; Laurila K; Reunala T; Hervonen K; Salmi T; Lindfors K
Nutrients; 2020 Feb; 12(2):. PubMed ID: 32069794
[TBL] [Abstract][Full Text] [Related]
3. Dermatitis herpetiformis: a cutaneous manifestation of coeliac disease.
Collin P; Salmi TT; Hervonen K; Kaukinen K; Reunala T
Ann Med; 2017 Feb; 49(1):23-31. PubMed ID: 27499257
[TBL] [Abstract][Full Text] [Related]
4. Elevation of IgA anti-epidermal transglutaminase antibodies in dermatitis herpetiformis.
Hull CM; Liddle M; Hansen N; Meyer LJ; Schmidt L; Taylor T; Jaskowski TD; Hill HR; Zone JJ
Br J Dermatol; 2008 Jul; 159(1):120-4. PubMed ID: 18503599
[TBL] [Abstract][Full Text] [Related]
5. Serum transglutaminase 3 antibodies correlate with age at celiac disease diagnosis.
Salmi TT; Kurppa K; Hervonen K; Laurila K; Collin P; Huhtala H; Saavalainen P; Sievänen H; Reunala T; Kaukinen K
Dig Liver Dis; 2016 Jun; 48(6):632-7. PubMed ID: 27026081
[TBL] [Abstract][Full Text] [Related]
6. Dermatitis herpetiformis: pathognomonic transglutaminase IgA deposits in the skin and excellent prognosis on a gluten-free diet.
Reunala T; Salmi TT; Hervonen K
Acta Derm Venereol; 2015 Nov; 95(8):917-22. PubMed ID: 26059085
[TBL] [Abstract][Full Text] [Related]
7. Separate Gut Plasma Cell Populations Produce Auto-Antibodies against Transglutaminase 2 and Transglutaminase 3 in Dermatitis Herpetiformis.
Das S; Stamnaes J; Kemppainen E; Hervonen K; Lundin KEA; Parmar N; Jahnsen FL; Jahnsen J; Lindfors K; Salmi T; Iversen R; Sollid LM
Adv Sci (Weinh); 2023 Sep; 10(25):e2300401. PubMed ID: 37424036
[TBL] [Abstract][Full Text] [Related]
8. Intestinal Production of Anti-Tissue Transglutaminase 2 Antibodies in Patients with Diagnosis Other Than Celiac Disease.
Maglio M; Ziberna F; Aitoro R; Discepolo V; Lania G; Bassi V; Miele E; Not T; Troncone R; Auricchio R
Nutrients; 2017 Sep; 9(10):. PubMed ID: 28934109
[TBL] [Abstract][Full Text] [Related]
9. Small bowel transglutaminase 2-specific IgA deposits in dermatitis herpetiformis.
Salmi TT; Hervonen K; Laurila K; Collin P; Mäki M; Koskinen O; Huhtala H; Kaukinen K; Reunala T
Acta Derm Venereol; 2014 Jul; 94(4):393-7. PubMed ID: 24352382
[TBL] [Abstract][Full Text] [Related]
10. Prediction of clinical and mucosal severity of coeliac disease and dermatitis herpetiformis by quantification of IgA/IgG serum antibodies to tissue transglutaminase.
Dahlbom I; Korponay-Szabó IR; Kovács JB; Szalai Z; Mäki M; Hansson T
J Pediatr Gastroenterol Nutr; 2010 Feb; 50(2):140-6. PubMed ID: 19841593
[TBL] [Abstract][Full Text] [Related]
11. Co-localization of IgA and TG3 on healthy skin of coeliac patients.
Cannistraci C; Lesnoni La Parola I; Cardinali G; Bolasco G; Aspite N; Stigliano V; Picardo M
J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):509-14. PubMed ID: 17373979
[TBL] [Abstract][Full Text] [Related]
12. Intestinal titres of anti-tissue transglutaminase 2 antibodies correlate positively with mucosal damage degree and inversely with gluten-free diet duration in coeliac disease.
Tosco A; Auricchio R; Aitoro R; Ponticelli D; Primario M; Miele E; Rotondi Aufiero V; Discepolo V; Greco L; Troncone R; Maglio M
Clin Exp Immunol; 2014 Sep; 177(3):611-7. PubMed ID: 24773630
[TBL] [Abstract][Full Text] [Related]
13. Transglutaminase autoantibodies in dermatitis herpetiformis and celiac sprue.
Marietta EV; Camilleri MJ; Castro LA; Krause PK; Pittelkow MR; Murray JA
J Invest Dermatol; 2008 Feb; 128(2):332-5. PubMed ID: 17762854
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to tissue transglutaminase as serologic markers in patients with dermatitis herpetiformis.
Dieterich W; Laag E; Bruckner-Tuderman L; Reunala T; Kárpáti S; Zágoni T; Riecken EO; Schuppan D
J Invest Dermatol; 1999 Jul; 113(1):133-6. PubMed ID: 10417632
[TBL] [Abstract][Full Text] [Related]
15. TG6 Auto-Antibodies in Dermatitis Herpetiformis.
Hadjivassiliou M; Reunala T; Hervonen K; Aeschlimann P; Aeschlimann D
Nutrients; 2020 Sep; 12(9):. PubMed ID: 32967363
[TBL] [Abstract][Full Text] [Related]
16. Dermatitis herpetiformis sera or goat anti-transglutaminase-3 transferred to human skin-grafted mice mimics dermatitis herpetiformis immunopathology.
Zone JJ; Schmidt LA; Taylor TB; Hull CM; Sotiriou MC; Jaskowski TD; Hill HR; Meyer LJ
J Immunol; 2011 Apr; 186(7):4474-80. PubMed ID: 21335491
[TBL] [Abstract][Full Text] [Related]
17. T Cell Response Toward Tissue-and Epidermal-Transglutaminases in Coeliac Disease Patients Developing Dermatitis Herpetiformis.
Caproni M; Capone M; Rossi MC; Santarlasci V; Maggi L; Mazzoni A; Rossettini B; Renzi D; Quintarelli L; Bianchi B; Ninci A; Lami G; Calabrò A; Cosmi L; Annunziato F; Liotta F
Front Immunol; 2021; 12():645143. PubMed ID: 33959126
[TBL] [Abstract][Full Text] [Related]
18. Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits.
Stenman SM; Lindfors K; Korponay-Szabo IR; Lohi O; Saavalainen P; Partanen J; Haimila K; Wieser H; Mäki M; Kaukinen K
BMC Immunol; 2008 Feb; 9():6. PubMed ID: 18312620
[TBL] [Abstract][Full Text] [Related]
19. Dermatitis herpetiformis.
Kárpáti S
Clin Dermatol; 2012; 30(1):56-9. PubMed ID: 22137227
[TBL] [Abstract][Full Text] [Related]
20. Low prevalence of IgA anti-transglutaminase 1, 2, and 3 autoantibodies in children with atopic dermatitis.
Ress K; Teesalu K; Annus T; Putnik U; Lepik K; Luts K; Uibo O; Uibo R
BMC Res Notes; 2014 May; 7():310. PubMed ID: 24885370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
